BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4786285)

  • 1. [Hospital treatment of neurotic and psychic reactive clinical pictures with a new benzodiazepin derivative (author's transl)].
    Koufen H; Schulte PW; Consbruch U
    Med Klin; 1973 Dec; 68(51):1701-5. PubMed ID: 4786285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demetrin (prazepam) in clinical therapy (author's transl)].
    Böhme K
    Munch Med Wochenschr; 1973 Nov; 115(46):2103-6. PubMed ID: 4591381
    [No Abstract]   [Full Text] [Related]  

  • 3. [Open clinical testing of 7-chlor-1-(cyclopropylmethyl)-1, 3-dihydro-5 phenyl-2H-1, 4 benzodiazepine-2-one(Prazepam) in the indication as tranquilizing and antispastic agent].
    Bruck J; Tshabitscher H
    Nervenarzt; 1973 Oct; 44(10):547-9. PubMed ID: 4587871
    [No Abstract]   [Full Text] [Related]  

  • 4. Prazepam in the treatment of anxiety and tension: a clinical study of a new benzodiazepine derivative.
    Kingstone E; Villeneuve A; Kossatz I
    Curr Ther Res Clin Exp; 1966 Apr; 8(4):159-63. PubMed ID: 4956321
    [No Abstract]   [Full Text] [Related]  

  • 5. Early phase-II semi double-blind study of the new alkaline propanolamine derivative enciprazine (short communication).
    Linden M; Helmchen H; Müller-Oerlinghausen B
    Arzneimittelforschung; 1988 Jun; 38(6):814-6. PubMed ID: 3178922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic experiences with a new benzodiazepine-derivative Demetrin].
    Recke A
    Fortschr Med; 1974 Jul; 92(20):871-3. PubMed ID: 4606029
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side-effects and changes of some physiological parameters after administration of a single 20 to 30 mg dose of prazepam. Double-blind study].
    Cazzato G; Zorzon M; Torre Antonello P; Carraro N; Monti F
    Clin Ter; 1983 Sep; 106(5):339-50. PubMed ID: 6641102
    [No Abstract]   [Full Text] [Related]  

  • 8. Prazepam in the treatment of psychoneurotic outpatients: a brief report.
    Silver D; Ban TA; Kristof FE; Saxena BM; Bennett J
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):596-8. PubMed ID: 4981302
    [No Abstract]   [Full Text] [Related]  

  • 9. Prazepam in anxiety: a controlled clinical trial [proceedings].
    Rickels K; Downing RW
    Psychopharmacol Bull; 1977 Apr; 13(2):19-21. PubMed ID: 323905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Key-structure of the N-5 questionnaire from the psychopharmacological and psychotherapeutic point of view].
    Dolezal V; Hausner M
    Cesk Psychiatr; 1973 Apr; 69(2):88-95. PubMed ID: 4703137
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the immediate effect of a new imidazolidinone derivative].
    Wolbergs E; Ziolko HU
    Arzneimittelforschung; 1966 Feb; 16(2):323-5. PubMed ID: 4861664
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sulpiride in pediatrics].
    Fortschr Med; 1973 Apr; 91(11):488-94. PubMed ID: 4702394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical observation of a new anxiolytic phenothiazine derivative].
    Vieira JC
    Hospital (Rio J); 1970 Oct; 78(4):1147-53. PubMed ID: 5313973
    [No Abstract]   [Full Text] [Related]  

  • 16. Hostility conflict in neurotic patients who prematurely terminate drug treatment.
    Downing RW; Rickels K; Horn NL
    J Nerv Ment Dis; 1970 Sep; 151(3):211-8. PubMed ID: 5460508
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug treatment of spasticity (author's transl)].
    Jelasic F
    MMW Munch Med Wochenschr; 1974 Apr; 116(16):851-4. PubMed ID: 4209449
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical trial of EXP 338 in the treatment of a neurotic population.
    Claghorn JL; Schoolar JC
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):279-81. PubMed ID: 4969833
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.
    Sugerman AA; Miksztal MW; Freymuth HW
    J Clin Pharmacol New Drugs; 1971; 11(5):383-7. PubMed ID: 4935717
    [No Abstract]   [Full Text] [Related]  

  • 20. Item analysis of the differences in comparative drug effects as yielded by the self-rating questionnaire SCL-90.
    Boleloucký Z; Plevová J; Kamenická V; Náhunek K
    Act Nerv Super (Praha); 1979 Sep; 21(2):123-4. PubMed ID: 42256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.